This edition of Research Ethics Roundup covers African-American participation in DNA testing, difficulties recruiting participants for Alzheimer's trials, even when results are promising, the deaths of eleven babies born to mothers in a Dutch drug trial involving generic Viagra, and a call for research misconduct investigations across Britain by the United Kingdom’s House of Commons science and technology committee.

“But before they sign up, many African-Americans have to overcome concern about potential misuse of DNA results and mistrust of health research, which has not always benefited them and was sometimes conducted without their consent.”

“The irony is that the science has never been more promising,” Mr. Dwyer said. “How many promising drugs will be abandoned or their evaluation seriously delayed? Some good science is going to be left on cutting-room floor.”

“Between 10 and 15 women are waiting to find out if their child has been affected by the drug. It is feared that the drug caused high blood pressure in the lungs, leading to the babies receiving too little oxygen. There is nothing to suggest the trial was mishandled.”

We need more investigations into research misconductThe leader of the United Kingdom’s House of Commons science and technology committee calls for research misconduct investigations across Britain to increase and suggests an independent institution be created to conduct such investigations.

"I’d actually like to see the number of investigations increasing.... We need to take a mature approach to reporting misconduct figures that recognises that no human endeavour is immune to error, questionable practices, and even fraud."

Latest Tweets

Blogs of interest

Mission

Public Responsibility in Medicine and Research (PRIM&R) advances the highest ethical standards in the conduct of biomedical, behavioral, and social science research. We accomplish this mission through education, membership services, professional certification, public policy initiatives, and community building.